Correction: A randomized, open-label, parallel, multi-center Phase IV study to compare the efficacy and safety of atorvastatin 10 and 20 mg in high-risk Asian patients with hypercholesterolemia.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 34669740.
- Also identified by DOI 10.1371/journal.pone.0259072 and PMC identifier 8528292.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0245481.].